Covered recipient · General Payments record
ABRAR AHMAD
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2018–2024
$3,563.14
- Reported across 204 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.15 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $190.96 | 7 |
| Gilead Sciences, Inc. | $129.37 | 6 |
| PFIZER INC. | $51.71 | 2 |
| Paratek Pharmaceuticals, Inc. | $35.11 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.54 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183422 | CMS |
| ABBVIE INC. | $27.23 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183424 | CMS |
| ABBVIE INC. | $24.98 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183426 | CMS |
| ABBVIE INC. | $29.84 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183428 | CMS |
| ABBVIE INC. | $29.15 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183430 | CMS |
| ABBVIE INC. | $25.57 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183432 | CMS |
| ABBVIE INC. | $25.65 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183434 | CMS |
| Gilead Sciences, Inc. | $21.30 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133839298 | CMS |
| Gilead Sciences, Inc. | $18.56 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133839300 | CMS |
| Gilead Sciences, Inc. | $24.71 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133839302 | CMS |
| Gilead Sciences, Inc. | $21.75 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133839304 | CMS |
| Gilead Sciences, Inc. | $20.64 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133839306 | CMS |
| Gilead Sciences, Inc. | $22.41 | 12/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133839308 | CMS |
| Paratek Pharmaceuticals, Inc. | $19.87 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113889742 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.24 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113889744 | CMS |
| PFIZER INC. | $23.74 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131607040 | CMS |
| PFIZER INC. | $27.97 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131606217 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.